MVM is a venture capital and growth equity investor that invests broadly across the healthcare sector, including biotechnology, specialty pharmaceuticals, medical technology, diagnostics, life science tools, consumer healthcare, veterinary medicine, healthcare services, and healthcare IT.
MVM focuses on the risk and return characteristics of an investment opportunity rather than the traditional criteria often used to define venture capital and growth equity investments in healthcare. As such, we are not prescriptive with respect to investment stage, company stage, sub-sector, or therapeutic category.
MVM does not have fixed criteria for investment size but we expect to make aggregate investments of $10 to 20 million in each of our portfolio companies over the lifetime of our holdings in the company.
MVM has the flexibility to invest in any investment security, including those of listed companies as well as debt instruments.
MVM will consider investing in companies based anywhere in the world.